DEFINING ULTRA‐HIGH‐RISK DLBCL PATIENTS PRIOR TO INITIAL TREATMENT BASED ON AN INTEGRATIVE HOST AND DISEASE PROGNOSTIC SCORE (FROM REMARC STUDY)

Autor:	Catherine Thieblemont, Loïc Chartier, A. Cottereau, O. Casasnovas, Michel Meignan, Véronique Baud, A. Judet, Hervé Tilly, Laetitia Vercellino, J.-F. Deux
Rok vydání:	2021
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hematology General Medicine Disease Ultra high risk Prognostic score Internal medicine medicine Initial treatment business Host (network)
Zdroj:	Hematological Oncology. 39
ISSN:	1099-1069 0278-0232
DOI:	10.1002/hon.17_2879
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::212f7bb74e90de368987ded7ccd97bd4 https://doi.org/10.1002/hon.17_2879 Zobrazit plný text záznamu Plný text